Alexis Kayser

By Alexis Kayser

Healthcare Editor

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


This is a preview of the September 25 edition of Access Health—Tap here to get this newsletter delivered straight to your inbox.


Good morning. I've got a jam-packed edition for you today—exclusive updates from Epic and UpToDate, a candid conversation on value-based care execution, and one CISO's strategy for keeping weight off on the road.

Read More on Health Care

But first, let's talk about President Donald Trump's comments on Tylenol and autism.

Physicians and nurses have been eager to speak out in the wake of Trump's remarks on Monday, where he falsely claimed that Tylenol use during pregnancy causes autism in offspring. Unsurprisingly, the president's statements are causing a stir.

I've been covering hospital operations for more than three years, and one of the most frequent complaints I hear from doctors is some version of: "I didn't spend a decade in medical school for a suit with an MBA to tell me how to care for my patients." Sometimes the rhetoric is gentler. Oftentimes, it's harsher.

That annoyance appears to have heated up over the past few days, evolving into stronger emotions: fear, shock, rage. This feels different than a private equity firm cutting staff without regard for quality outcomes (more on that in the next section), or a payer denying necessary coverage for a patient they've never met. One of the most powerful people in the world struggled to pronounce "acetaminophen," then gave multiple pieces of unfounded medical advice, saying, "This is based on what I feel."

You can view a transcript of his remarks here—which also include unsubstantiated recommendations to space out vaccines and skip the hepatitis B vaccination for infants and children.

Newsweek was unable to find reputable studies that verified the exact figures Trump has recited. An August evaluation from Harvard T.H. Chan School of Public Health did identify 27 studies that showed a positive association between acetaminophen use during pregnancy and neurodevelopmental disorders, like ADHD and autism spectrum disorder (ASD). Nine studies did not find a link. Researchers have asserted that while these studies may identify a correlation, they do not prove causation.

The President, however, said that women should "tough it out" and avoid using Tylenol while pregnant.

Medical experts are speaking out after the president's speech, trying to slow the snowball of misinformation.Multiple health care and professional organizations, including the American College of Emergency Physicians, the Autism Science Foundation and UC Davis' MIND Institute, have issued statements assuring the public that acetaminophen is safe to take during pregnancy. Tylenol itself released an Instagram video asserting that there is "no proven link" between the medication and autism.

Meanwhile, individual clinicians are concerned that this could have adverse effects on pregnant women's health and the health of their unborn children. Tylenol is one of the only pain relievers that is safe to use during pregnancy, and it also helps with reducing fevers. High temperatures in pregnant patients have been proven to be detrimental to fetuses.

One of the nurses I spoke with was Stephanie Fassett, director of accreditation and nursing professional development at the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). She told me that Trump's remarks were "really surprising," as no one in the medical or nursing communities has given any credibility to such claims.

"I am concerned that it will cause more confusion and distrust in the medical and nursing communities, with patients not knowing what to believe and hearing these different, conflicting sides," Fassett said. "Who can they trust, and who can they lean on?"

Hospital leaders will play an essential role in building that trust—both with their employees and their patients. Fassett suggested that hospitals and health systems look to their medical and nursing associations for guidance on this particular issue.

"We've all come out and reviewed the research, we've reviewed the evidence," she said. "And we feel very confident with the research that is available now that acetaminophen is still safe, and there should be no changes to practice at this time."

How is your health system working to combat medical misinformation? Email me at a.kayser@newsweek.com and let me know.

Trump talks about autism

...


In Other News

Major health care headlines from the week


Pulse Check

Executive perspectives on key industry issues

Courtney Fortner is the president and CEO of Navvis, which works with health systems, health plans and physician organizations to shift from fee-for-service to value-based care models. I spoke with her last month on all things VBC. Find a portion of our interview below:

Editor's Note: Responses have been lightly edited for length and clarity.

People define value-based care in different ways. What does the term mean to you?

Oh man, that's such a good question, because I think it has a lot of baggage with it. We, even to this point, kind of get a visceral reaction when we say "value-based care."

What's interesting is that when we take that word, that terminology, out of the equation, the conversation ends up being attributes of value-based care. So when we talk about quality or experience, we'll have people say, "We don't really want to do the value-based care journey, but we do want to improve our quality. We do want to improve our patient experience. We do want to lower the total cost of care." So they're saying the things that are what we think of as value-based care. But there's then just this baggage around what it means.

I think it's been so tightly tied to Medicare Advantage. And there's been a lot of challenges in MA, especially in 2024. I think as people start to understand the value of value-based care to the organizations—particularly that, again, it's not saying no volume, it's an "and" strategy—they then really start to appreciate that discussion.

To us, it really is about patient outcomes. It's about doing the right thing for the patient. Now, in order to do that, there are a lot of things that come with it, and it relies very heavily on the physician: so a lot of levers, a lot of mechanisms. But at the end of the day, when we talk about value-based care, it just is what it says. It's providing value to patients, particularly as we think about their outcomes.

One common conception about value-based care is that it takes some time to see a real return on that investment, because, of course, the population takes time to become healthier. How do you describe that give and take to health system leaders and to payers?

There are two ways of looking at value-based care in terms of its return. One is what you just said, certainly, it's the long game. I mean, these are multiyear strategies. And frankly, it's just becomes a way that you operate. It's not just a project, it's not an initiative. It really is a long game.

We also try to look for the low hanging fruits that do yield a quick return in value-based care, and those opportunities are out there. When we think about, for example, some of our partners start just in P for P, P for Q value-based contracts. Those are really focused on quality. Some of those quality dollars for those systems are available in pretty real time.

But the real, long-term effect of value-based care and doing it right is certainly a long game. This is where volume becomes really, really important. When we go into a system, they may say, look, we don't even have the dollars to fund a population health strategy or even start to think about moving our contracts, because we then need to build the operational support to deliver on those value-based contracts. And we just can't even think about that right now.

But what we do know is that, hey, hospital, you have a problem with your beds being filled and you can't get your patients out, and you actually have backfill waiting to come into your organization. So then we start to work with them on their acute patient throughput, so getting those patients out effectively, getting them to the right next level of care, and these systems are then able to get their backfill in. And it's really better for the patient, it's better for the system, and it creates a little bit of reprieve, some breathing room from a financial standpoint, so they can start to see the return there.

What do you see as the main behaviors or practices that physicians have to change in order to be successful in a value-based care model?

We really believe in behavioral economics. We very much believe in aligned incentives. Sometimes a physician wants to change their behavior, but their paycheck and their livelihood doesn't allow them to. There's an element of that that really comes down to partnering with our system partners to, again, incorporate those value elements into the physician compensation model so that those physicians can change their behaviors. That's one element of it.

The other piece that we focus on, we call it our Surround Care Academy. That's the physician peer-to-peer training program. A key element of that is early disease recognition. A lot of folks will go into practices and talk about HCC coding, but really, when you take a step back and you think about the purpose of HCC coding, it's to capture the disease state of your patient accurately and early enough so that you can then manage that.

So we've shifted that terminology to early disease recognition. Like, we're not talking about codes, we're not talking about coding. These physicians are talking about, how do you extend the longevity of the life of your patient? Because that's really, at the end of the day, what they went to school to do.

It takes a different kind of conversation to start to shift that mindset. But again, the aligned incentives piece is really important so that they are able to spend more time with their patients, not have to see 35 patients a day, and just kind of be on that cycle because that's how they're incentivized.


C-Suite Shuffles

Where health care leaders are coming and going


Executive Edge

How health care leaders are managing their own health

Shev Partovi

...

Yesterday, I spoke with Shez Partovi, Philips' chief innovation and strategy officer and head of its health care informatics business. He's had a long career in health care and health tech—working as a practicing neuroradiologist before moving into digital- and business-focused roles at Dignity Health, Amazon Web Services (AWS) and eventually Philips.

I'm excited to bring you some of his thoughts on AI in next week's edition. But for now, here's what Partovi told me about maintaining his own health with a loaded travel schedule. We had a good laugh about it, but I consider it sound advice:

Editor's Note: Responses have been lightly edited for length and clarity.

Check back next week for Partovi's insights on AI policy and change management.


This is a preview of the September 25 edition of Access Health—Tap here to get this newsletter delivered straight to your inbox.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines